Article Data

  • Views 601
  • Dowloads 110

Case Reports

Open Access

Malignant struma ovarii with synchronous papillary thyroid carcinoma: a rare diagnosis

  • S. Proença1,*,
  • M. Mouraz1
  • P. Conde1
  • H. Santos e Pereira1
  • F. Nunes1

1Department of Gynecology and Obstetrics, Hospital de Cascais Dr. José de Almeida, Cascais (Portugal)

DOI: 10.12892/ejgo3575.2018 Vol.39,Issue 1,February 2018 pp.137-139

Published: 10 February 2018

*Corresponding Author(s): S. Proença E-mail: saritaproenca@gmail.com

Abstract

Struma ovarii is a rare form of ovarian tumor, represented in more than 50% by thyroid tissue. Malignant transformation is a rare presentation and comprises about 5% of cases. The authors report a female with papillary thyroid carcinoma arising in struma ovarii, diagnosed after surgery for a right ovarian mass. Thyroid examination showed two nodular lesions in the left lobe. Total thyroidect my was performed and histology showed a papillary carcinoma, discordant in terms of ovarian tissue, synchronous to the ovary. Radioiodine ablation of residual thyroid tissue was performed and levothyroxine mildly-suppressive treatment was begun. Although the rareness of association, it is of extreme importance that patients with malignant struma ovarii undergo imaging of thyroid gland for study of coexistent disease.


Keywords

Ovarian neoplasm; Struma ovarii; Thyroid neoplasm; Ovarian teratoma

Cite and Share

S. Proença,M. Mouraz,P. Conde,H. Santos e Pereira,F. Nunes. Malignant struma ovarii with synchronous papillary thyroid carcinoma: a rare diagnosis. European Journal of Gynaecological Oncology. 2018. 39(1);137-139.

References

[1] Zekri J.M., Manifold I.H., Wadsley J.C.: “Metastatic struma ovarii: late presentation, unusual features and multiple radioactive iodine treatments”. Clin. Oncol. (R. Coll. Radiol.), 2006, 18, 768.

[2] O’Neill J.P., Burns P. Kinsella J.: “Papillary type thyroid carcinoma in an ovarian struma”. J. Reprod. Med., 2002, 47, 943.

[3] Yassa L., Sadow P., Marqusee E.: “Malignant struma ovarii”. Nat. Clin. Pract. Endocrinol. Metab., 2008, 4, 469.

[4] Brusca N., Del Duca S.C., Salvatori R., D'Agostini A., Cannas P., Santaguida M.G., et al.: “A case report of thyroid carcinoma confined to ovary and concurrently occult in the tyroid:is conservative treatment always advised?” Int. J. Endocrinol. Metab., 2015, 13, e18220.

[5] Makani S., Kim W., Gaba A.R.: “Struma ovarii with a focus of papilarry thyroid cancer: a case report and review of the literature”. Gynecol. Oncol., 2004, 94, 835.

[6] Zannoni G.F., Gallota V., Legge F., Tarquini E., Scambia G., Ferrandina G.: “Pseudo-Meigs’ Syndrome associated with malignant struma ovarii: a case report”. Gynecol. Oncol., 2004, 94, 226.

[7] Navarro M.D., Tan M.A.L., Lovecchio J.L., Hadju S.I.: “Case report: malignant struma ovarii”. Ann. Clin. Lab. Sci., 2004, 34, 107.

[8] Hatami M., Breining D., Owers R.L., Del Priore G., Goldberg G.L.: “Malignant struma ovarii - a case report and review of literature”. Gynecol. Obstet. Invest., 2008, 65, 104.

[9] Marti J.L, Clark V.E., Harper H., Chhieng D.C., Sosa J.A., Roman S.A.: “Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases”. Thyroid, 2012, 22, 400.

[10] Leong A., Roche P.J., Paliouras M., Rochon L. Trifiro M., Tamilia M.: “Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma”. J. Clin. Endocrinol. Metab., 2013, 98, 4599.

[11] O’Neill J.P., Burns P., Kinsella J.: “Papillary type thyroid carcinoma in an struma ovarii”. Ir. J. Med. Sci., 2012, 181, 115.

[12] Janszen E.W., Van Doorn H.C., Ewing P.C., de Krijger R.R., de Wilt J.H., Kam B.L., de Herder W.W.: “Malignant struma ovarii”. Ned. Tijdschr. Geneeskd., 2008, 152, 1647.

[13] Krishnammurthy A., Ramshankar V., Vaidyalingam V., Majhi U.: “Synchronous papillary carcinoma thyroid with malignant struma ovarii: A management dilemma”. Indian J. Nucl. Med., 2013, 28, 243.

[14] Barrera J.R., Manalo L.A., Ang F.L.L.: “Papillary thyroid-type carcinoma arising from struma ovarii”. BMJ Case Rep., 2012, 2012, pii: bcr0320126145. Corresponding Author:

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top